CAS: 7791-07-3; Sodium Perchlorate Hydrate

该化合物是一种无机化合物,配有化学配方NaClO4H2O.它看起来像一种白色晶状固体,在水中高度溶解,在各种化学应用中成为有用的试剂;该化合物的特点是其强烈氧化特性,可归因于高氯离子(ClO4),在正常条件下稳定,但在受热或有消毒剂时,高氯酸钠单氢酸盐可以分解,有可能释放氯气;它通常用于烟火,炸药和火箭推进剂中的氧化剂;此外,它在分析化学和实验室试剂中也有应用;虽然一般认为处理安全,但应采取预防措施,因为其氧化性质在与可燃材料接触时可能会造成火灾或爆炸的危险;适当储存在冷却,干燥的地方,远离不相容的物质对于保持其稳定性和安全至关重要.

英文名称Sodium Perchlorate Hydrate
中文名称高氯酸钠一水化合物
IUPAC名称sodium perchlorate hydrate
其它别名Sodiumperchlorate (NaClO4) monohydrate; Sodium perchlorate monohydrate
CAS编号7791-07-3
MFCD编号:MFCD00149164
EINECS号:616-573-0
FDA UNII编号:G4H485LHCW
分子式:ClH2NaO5
分子量:140.45
产品CID: 2533896
产品分类无机化工 → 无机盐 → 金属卤化物及卤酸盐

相似结构搜索
InChIKey: IXGNPUSUVRTQGW-UHFFFAOYSA-M
IXGNPUSUVRTQGW-UHFFFAOYSA-M…
计算化学: 氢键受体数5.0氢键供体数2.0可旋转键数0.0

MSDS等安全信息

GHS象形图
GHS符号GHS03 & GHS07;
注释: Flame over circle & Exclamation mark
危险类别Ox. Sol. 1
急性毒性类别4(经口)
严重眼刺激类别2
特定目标器官毒性 - 单次接触类别3
特定目标器官毒性-重复接触类别2
皮肤腐蚀/刺激类别2
警示词Danger(危险)
危险描述H271 |可能引起火灾或爆炸;强氧化剂.
H302 |吞咽有害.
H319 |造成严重眼刺激.
H335 |可能引起呼吸道刺激.
H373 |长期或反复接触可能损害器官.
H315 |造成皮肤刺激.
防范说明P210-P220-P264-P280-P283-P305+P351+P338
危险等级5.1
UN编号UN 1502 5.1/PG 2
危险品标志O,Xn,Xi
包装等级II
安全声明17-26-27-36/37/39-22-13
危险类别码9-22-36/37/38-8
WGK Germany3

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

perchloric acid water sodium hydrogencarbonate sodium carbonatechloride chlorate [(η5-C5H5)Ru(1,10-phenanthroline)(PPh3)]ClO4 [(η5-C5H5)Ru(ethylenediamine)(PPh3)]ClO4

合成工艺路线路线简述

专利信息

专利号:US-2008188658-A1
优先权日:2002-08-14
标题 :Novel synthesis of gatifloxacin

专利号:US-2018170949-A1
优先权日:2014-12-30
标题 :Synthesis of cephalosporin compounds

专利号:US-2007072868-A1
优先权日:2002-08-14
标题:Novel synthesis of gatifloxacin

专利号:CA-2495271-A1
优先权日:2002-08-14
标题:Synthesis of gatifloxacin

专利号:US-4093812-A
优先权日:1975-03-25
标题:(Nitrofuryl)pyrazoles, their synthesis and use, and compositions containing them
发明人：RAINER GEORG
权利人:BYK GULDEN LOMBERG CHEM FAB
摘要:3-(5-Nitro-2-furyl)pyrazoles unsubstituted in the 5-position and 5-(5-nitro-2-furyl)pyrazoles unsubstituted in the 3-position are antimicrobials and disinfectants. The compounds are structurally represented by one of the formulae: ##STR1## wherein A is --CHO, --CN, --COOH, a protected or derived aldehyde group or a protected or derived carboxylic acid group; n B is 5-nitro-2-furyl; n R 1 is --H, substituted or unsubstituted hydrocarbyl (saturated or unsaturated; acyclic, alicyclic or aromatic; or araliphatic); substituted or unsubstituted (cycloaliphatic or aromatic) heterocyclic or acyl (carboxylic or carbonic acid); n R 2 is --H; and n n is a positive whole number of at most 2.

专利号:JP-2006516152-A
优先权日:2002-08-14
标题 :Synthesis of gatifloxacin